Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
416.43%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 34.81Close
$ 10.84 - $ 35.65 52-Week Range
Ticker Information
Ticker
INBXCompany Name
INHIBRX BIOSCIENCES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQINHIBRX BIOSCIENCES INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
INBX - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 5.83M | 416.43% | $ 1.4M |
| 3/31/2025 | $ 8.05M | 4025% | $ 200K |
| 12/31/2024 | $ 13.49M | 6745.5% | $ 200K |
| 12/31/2023 | $ 31.84M | 1768.89% | $ 1.8M |
Key Performance Insights, Last 5 Years
- INHIBRX BIOSCIENCES INC's latest trailing twelve months (TTM) Int. Exp. % stands at 1768.89%.
- Over the past 5 years, INHIBRX BIOSCIENCES INC's average Int. Exp. % has been 3238.95%.
- The median Int. Exp. % for INHIBRX BIOSCIENCES INC during this period was 2896.94%
- INHIBRX BIOSCIENCES INC reached its highest Int. Exp. % over the past 5 years at 6745.5%.
- The lowest Int. Exp. % recorded by INHIBRX BIOSCIENCES INC in the same timeframe 416.43%
INHIBRX BIOSCIENCES INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for INHIBRX BIOSCIENCES INC is calculated as follows: Int. Exp. [ $ 31.84M ] / Revenues [ $ 1.8M ]
(=) Int. Exp. % [ 1768.89% ] INBX - Interest Expense Margin, Last 5 years
416.43%
Minimum
Jun 30, 2025
6745.5%
Maximum
Dec 31, 2024
3238.95%
Average
2896.94%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.62% with a standard deviation of 2.19%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.48% |
| average | 1.62% |
| median | 0.79% |
| std | 2.19% |